Abstract Alagille syndrome (AGS) or arteriohepatic dysplasia is a rare but well-defined clinical entity that is usually inherited as an autosomal dominant trait. A limited number of patients carry a deletion in chromosome 20p, with 20pl 1.23-p12.2 as the area of minimal overlap. Recently, a family has been identified in which a balanced translocation with a breakpoint in 20p12 co-segregates with the AGS phenotype. Here, we report a three-generation family with AGS and in which the affected members have a normal karyotype. Linkage analysis was performed with markers from the 20p candidate region. A lod score of Z=2.96 was obtained with D20S27 at no recombination. Combining D20S27 and D20S61 to a single highly informative locus resulted in a maximum lod score of Z=+3.56 at | Haplotype analysis positioned AGS between D20S59 and D20S65, markers that define an interval of about 40 cM. Allelic loss was not observed for the tested markers and no abnormalities in the PAX 1 candidate gene were detected. These findings demonstrate that the locus on chromosome 20p could be responsible for AGS in cytogenetically normal patients and argues for a general role of this locus in the aetiology of AGS.
jor characteristics: interhepatic biliary hypoplasia, peripheral pulmonary artery stenosis, posterior embryotoxon, typical facies and butterfly vertebrae (Watson and Miller 1973; Alagille et al. 1975 Alagille et al. , 1987 Mueller 1987) . It is usually inherited as an autosomal dominant trait with almost complete penetrance (Dhome-Pollet et al. 1994) , whereas the severity of the disorder can vary considerably among affected relatives (Shulman et al. 1984) . The aetiology of AGS is largely unknown. An interstitial deletion at chromosome 20pl 1.2-p12 has been detected in a limited number of patients indicating that this chromosomal region encompasses a locus for AGS (Byrne et al. 1986; Schnittger et al. 1989; Zhang et al. 1990 ; Legius et al. 1990; Anad et al. 1990; Teebi et al. 1992; Desmaze et al. 1992) . This has been substantiated by the detection of a family in which a balanced translocation t(2;20) (q21.3;p 12) co-segregates with the AGS phenotype (Spinner et al. 1994) . However, the relevance of this locus for patients with no cytogenetic abnormalities remains to be demonstrated. Here, we report the results of linkage analysis in a three-generation family with an autosomal, dominantly inherited AGS using markers from the 20pl 1.2-p12 candidate region.
Materials and methods

Genotyping
Venous blood was sampled from the relevant family members of the present family (Fig. 1) , and genomic DNA was isolated by the procedure of Miller et al. (1988) . The following highly polymorphic microsatellite markers located at chromosome 20pl 1.2-p12 were employed in the analysis: D20S27, D20S41, D20S48, D20S50, D20S58, D20S59, D20S61, D20S65 and D20S66. Information concerning the relative order of these markers and the genetic distances (Fig. 2) was obtained from the literature Keith et al. 1992) and from the Genome Database. Genotyping involved polymerase chain reaction (PCR) amplification of 50ng genomic DNA in a total volume of 15 gl with 0.3 ~tM of each locus-specific primer, 200 gM of each dATP, dGTP, dTTP and 2.5 gM dCTP, 0.6 gCi c~32p-dCTP ( 10 mCi/ml, 3000 Ci]mmol; Amersham) in PCR buffer [50raM TRIS-HC1 pH9.0, 50mM KC1, 7raM
MgC12, 16mM (NH4)2804] with 0.06U SuperTaq DNA poly- merase (HT Biotechnology). Samples were denatured at 92~ for 5min and then subjected to 30 cycles of amplification: 92~ for 1 min, 55~ for 2min, 72~ for I min. PCR products were size-fractionated on 6.6% denaturing polyacrylamide gels. After electrophoresis at 60W for 3 h, gels were dried and the visualisation of allelic bands was achieved by overnight autoradiography using Kodak X-omat S films.
Linkage analysis
Linkage analysis was carried out using the MLINK option of the LINKAGE program package, version 5.1 (Lathrop et al. 1985) with an estimated disease gene frequency of 0.000014 and 94% penetrance (Dhome-Pollet et al. 1994) . The allele frequencies were obtained from the Genome Database for each marker. The clinical status of female I1.6 ( Fig. 1 ) was labeled as "unknown" in the linkage calculations.
Results
Clinical report
The family (Fig. 1) (III-1) was referred for genetic counselling to our department. Incorrectly, the referral diagnosis was autosomal recessive congenital liver fibrosis. Analysis of the pedigree and medical information from affected family members revealed the correct diagnosis, viz. AGS or arteriohepatic dysplasia. The diagnostic criteria as formulated by Mueller (1987) were applied to all studied family members, except to some individuals of generations I and II ( Fig. 1 ) who were either living in Indonesia or who refused an examination. With the exception of female |I.6, they were all obligate carriers, as revealed by their position in the pedigree. When considered necessary for the diagnosis, additional clinical investigations (echocardiography, ophthalmologic examination, radiography of spinal column, liver function test and physical examination for facial characteristics, viz. prominent forehead, deep set eyes, long nose with flattened tip and prominent chin) were performed. Cardiovascular abnormalities were detected in six out of eight patients, embryotoxon in two out of four, abnomlal liver functioning in five out of seven, vertebral abnormalities in three out of four, and six out of six patients had facial characteristics of AGS. Cytogenetic analysis of III-6 (Fig. 1) revealed a normal karyotype.
Mapping of the AGS locus
Linkage analysis was performed with markers from the 20p candidate region. Positive lod scores were obtained with most of these markers ( Fig. 2 Genetic map of the 20p candidate region. The relative order and the genetic distances (in cM) were obtained from the literature Keith et al. 1992) and from the Genome Database. The segment between D20S5 and D20S42, which is deleted in several AGS patients (Deleuze et al. 1994a) , is depicted by a dotted line. The location of the t(2;20) breakpoint is indicated by a solid double-headed arrow bination. Recent physical mapping studies by one of us (I.H.) indicate that D20S41 is located between D20S27 and D20S61. This alternative order of markers would not interfere with the present results, because a combination of D20S27, D20S41 and D20S61 into a single informative locus results in the same lod score at | To define the AGS locus more accurately, haplotypes were constructed with most of the markers employed for linkage analysis (Fig. l) . This places the disorder between D20S59 and D20S65, a region of approximately 40cM (Fig. 2) .
The gene for PAX 1, which has been mapped by fluorescence in situ hybridization at 20pl 1.2 (Schnittger et al. 1992) , has been proposed as a factor contributing to the AGS phenotype. To screen the DNA of patients from the present family for abnormalities of the PAX1 gene region, a probe for Southern blot hybridization was produced by PCR amplification using the published sequence (Burri et al. 1989 ). On Southern analysis, the normal band pattern and signal intensities indicate that the patients carry the two normal copies of the PAX1 gene (not shown).
Discussion
Linkage analysis of a large family with AGS has allowed us to map the disorder between D20S59 and D20S65 at 20pl 1.2-p12, a region of the genome that carries a deletion in some patients with AGS (Schnittger et al. 1989; Zhang et al. 1990; Legius et al. 1990; Anad et al. 1990; Teebi et al. 1992; Desmaze et al. 1992) and that harbours the breakpoint of a balanced translocation in patients from a single family (Spinner et al. 1994) . At present, our resuits do not permit a further refinement of the mapping of the AGS locus, because the segment of 20p that co-segregates with the disorder spans the minimal area of overlap of deletions and of the translocation breakpoint (Fig. 2) . Recently, additional markers have been reported that may be of use in obtaining a more concise location of AGS (Gyapay et al. 1994) . However, the main conclusion of the present study remains that the candidate locus on 20p could be responsible for AGS in karyotypically normal patients.
Studies in the mouse suggest that the gene for PAX1, located at 20pl 1.2, could play a role in the aetiology of AGS. The expression pattern of the murine homologue indicates that the Paxl protein is involved in the formation of the vertebral column , Wallin et al. 1994 , whereas mutations in the gene give rise to vertebral abnormalities as observed for the mouse strain "undulated" (Bailing et al. 1988) . However, in the present family, no abnormalities of this gene were detected by Southern analysis. Moreover, this gene and two other candidate genes coding for hepatic nuclear factor 313 and cystatin C, respectively, have recently been excluded from the area of minimal overlap of deletions associated with AGS (Deleuze et al. 1994b) . Apparently, hemizygosity of these genes is not involved in AGS. However, it cannot be excluded that an altered expression of those genes, as caused by positional effects, could influence the AGS phenotype in patients with a chromosomal abnormality.
In summary, although the segregation of a microdeletion or any other small chromosomal abnormality in the present family cannot be excluded, our findings show that the locus on chromosome 20p could underlie AGS in karyotypically normal patients, arguing for a general involvement of this locus in AGS. However, definitive evidence of a major locus for AGS on 20p has to await the identification of the gene(s).
